| 1 |
33140189 | IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells. | 2021 May |
2 |
| 2 |
34244307 | Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice. | 2021 Jul |
1 |
| 3 |
34524494 | Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells. | 2021 Nov |
1 |
| 4 |
30898149 | Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy. | 2019 Mar 21 |
1 |